Search results
Apr 2, 2024 · Acute promyelocytic leukemia is a rare disease, so what we know about survival rates comes from clinical trials involving people with low-risk and high-risk APL. One analysis of clinical trials involving low-risk APL cases found that 99% of people were alive four years after treatment.
- www.cancer.org
- › …
- › Treating Acute Myeloid Leukemia (AML)
Prompt diagnosis and treatment of acute promyelocytic leukemia (APL), the M3 subtype of acute myeloid leukemia (AML), is very important because people with APL can quickly develop life-threatening blood-clotting or bleeding problems if not treated.
May 24, 2023 · The 2-year APL-free survival rate for a person receiving ATRA-chemotherapy was 90%. However, without treatment, APL will generally result in death due to bleeding or infection-related...
May 7, 2015 · According to data from the National Cancer Institute SEER registry (from 1992 to 2007), the age-adjusted annual incidence (newly diagnosed cases) of APL was 0.23 per 100,000 persons. During that period, the average age of APL diagnosis was 44 years, which is younger than that of patients with other types of AML.
Mar 29, 2022 · Acute promyelocytic leukemia survival rate. According to the Leukemia and Lymphoma Society (LLS), APL is the most curable form of adult leukemia. Cure rates are high at 80–90%. However, healthcare professional experience with APL is important.
What is the survival rate for acute promyelocytic leukemia? At least 85–90 percent of children treated for APL are considered cured. Why choose St. Jude for your child’s acute promyelocytic leukemia treatment?
Acute promyelocytic leukemia (APL) is an aggressive type of acute myeloid leukemia (AML). It happens when there are too many of the blood-forming cells called promyelocytes in the blood and bone marrow.
Jun 26, 2023 · Acute promyelocytic leukemia is a relatively rare and comprises about 7% to 8% of adult AML cases. Acute promyelocytic leukemia is usually seen in middle-aged people with a median age of 47 years.
Apr 11, 2015 · Unlike most leukemias, acute promyelocytic leukemia (APL) has a very good prognosis, with long-term survival rates up to 90% following treatment.
- www.ncbi.nlm.nih.gov
- › Journal List
- › HHS Author Manuscripts
Acute promyelocytic leukemia (APL) boasts overall survival (OS) of >90% at 3 years and early mortality of <5% in recent clinical trials. Using a large National Cancer Database, we performed analysis of 7190 adults with APL to determine whether one-month mortality and OS of patients with APL treated in real-world practices mirror outcomes noted ...
